RIO DE JANEIRO, Feb. 2, 2011 /PRNewswire/ -- Amil Participacoes S.A. (BM&FBovespa: AMIL3; Bloomberg: AMIL3 BZ e APAR < GO >; Reuters: AMIL3 SA), the largest healthcare company in Brazil, in accordance with CVM Instruction 358, of January 3, 2002, informs that in the Board of Directors meeting held yesterday, it was decided that Amilpar, through its indirect subsidiary ESHO - Empresa de Servicos Hospitalares S.A., will exercise the right of first refusal for the acquisition of Hospital Samaritano (Clinica Medico Cirurgica Botafogo S.A.). The conditions and values are the same described in the Press Release of December 13, 2010. The decision taken by the independent board member was ratified by the other members of the Board of Directors, with abstention of Mr. Edson de Godoy Bueno and Ms. Dulce Pugliese de Godoy Bueno.
To access the .pdf full version of the document, visit our website at www.amilpar.com.br/ir
Amil Participacoes S.A. is the largest healthcare company in Brazil, according to the ANS, currently assisting over 5 million members in the states of Sao Paulo, Rio de Janeiro, Parana, Minas Gerais, Pernambuco, Bahia, Rio Grande do Norte and in Distrito Federal. It is also the managed care organization with the largest provider network in the country, including over (i) 3,600 hospitals; (ii) 62,000 polyclinics and outpatient facilities; and (iii) 11,200 laboratories and diagnostic imaging centers. Amil began its activities in 1978 and offers a wide range of healthcare plans for small, medium and large companies, as well as plans for individuals from all income segments, offering its members access to carefully selected healthcare service providers.
SOURCE Amil Participacoes S.A.